BioNTech SE
BNTX85.6000.66% ( +0.560 )
Financials
Q3 FY2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: BioNTech SE(BNTX) the Revenue is 1.46 B (-18.11%), Beat estimate;the EBIT is 431.99 M (+884.6%), Beat estimate;the EPS is 0.827 (+686.9%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.46B18.11%
1.18B34.04%
+0.28B15.93%
EBITExceed expectations
0.43B884.57%
0.11B297.25%
+0.32B587.32%
EPSExceed expectations
0.8268686.90%
0.7121605.50%
+0.114781.40%
Upcoming earnings report - FY2026 Q4 Earning Release
Available dateMar 2, 2027
Estimate Revenue439.22 M
Estimate EBIT--
Estimate EPS-1.778
Revenue
ActualEstimateUnit: USD
Quarterly
EBIT
ActualEstimateUnit: USD
Quarterly
Net income
ActualEstimateUnit: USD
Quarterly
EPS
ActualEstimateUnit: USD
Quarterly